-
Osobe Vidi sve
Ovjeren akaunt@BMS_ImmunOnc_US Raising awareness and education about Immuno-Oncology research. See our community guidelines: http://bit.ly/2pWKOod
New York, New York • immunooncologyhcp.com
-
#EmtoraBiosciences Presents Phase Ib Data in Low Grade#ProstateCancer Patients at the 2020#ASCOSITC Clinical#ImmunoOncology Symposium https://www.1stoncology.com/blog/emtora-biosciences-presents-phase-ib-data-in-low-grade-prostate-cancer-patients-at-the-2020-asco-sitc-clinical-immuno-oncology-symposium1234553848 … -
More than a thousand scientists have built the most detailed picture of cancer ever in a landmark study.
#genomics#cancerresearch#immunooncology#biomarkers#precisiononcologyhttps://lnkd.in/eN8zdhn -
Still spellbound by
#RSM 2020 Jephcott lecture by Sir#GregoryWinter. Fascinating talk on the unique technology, a Bicycle Drug Conjugate with a reduced molecular weight (for better tumour penetration) and profound specificity.#ImmunoOncology@RoySocMed@Bicycle_tx pic.twitter.com/1mPXKjbfBW
-
#CytoSorb helps reverse#cytokine release syndrome induced by#CAR_Tcell#immunotherapy Blood purification tech used w/ continuous renal replacement therapy &#tocilizumab http://doi.org/10.1097/CCE.0000000000000071 …#cancers#pediatrics#hematology#immunooncology pic.twitter.com/m4pzQpnZix
-
At ClearLight Biotechnologies we enable modern heroes to see more biology and explore further with Tru3D™. Get Started with CLARITY and Tru3D.
#biotech#drugdiscovery#science#biopharma#immunooncology#cancerresearch#preclinicalhttps://clearlightbiotechnologies.com/services/ -
SITC board member, Dr. Daniel S. Chen, debates Dr. Carl H. June on bispecifics vs. cell therapy, and which will have a greater impact on cancer care at the 6th Annual IO360° (
#IO360nyc) Summit, Feb 26-28 in NYC.#ImmunoOncology Register today at: http://ow.ly/8JR250y260B pic.twitter.com/lf4YFtPYTd
-
Clinical Translational Data Supporting
#DPXSurvivac Mechanism of Action to be Presented at 2020#ASCOSITC Clinical#ImmunoOncology Symposium$IMV https://www.1stoncology.com/blog/clinical-translational-data-supporting-dpx-survivac-mechanism-of-action-to-be-presented-at-2020-asco-sitc-clinical-immuno-oncology-symposium1234553830 … -
Very excited to announce our
#SeriesB#financing! The support from our existing and new investors will enable us to advance our full-ecosystem#microbiome biotherapeutics and expand their clinical application. https://bit.ly/2GTZnUA#oncology#hematology#GvHD#immunooncology pic.twitter.com/V30rH55tqI
-
Read our Q&A on
#combinationtrials from Chris Learn & Martin Lachs regarding their success in the#Immunooncology field. Read the full article here http://ow.ly/5dSY50ybpxH#WorldCancerDay
#WorldCancerDay2020
pic.twitter.com/5JkW3JO9SQ
-
Two exciting
#Immunooncology projects we are involved in, using non-adherent cells and HT flow cytometry with the iQue, are looking at re-activating “exhausted” T-cells so they can start kill cancer cells again. One is with@LabDac in@UoDLifeSciences#tcells#WorldCancerDay
pic.twitter.com/MHCNz3Vw1m -
Today we mark
#WorldCancerDay
- in recognition of all those working to beat #cancer and transform lives#WCD2020
#immunooncology pic.twitter.com/yOZEsT2IFD
-
This World Cancer Day, we recognise that our commitment to act will lead to powerful progress in reducing the global impact of cancer. Together we can win the battle against
#cancer#immunooncology#oncology#worldcancerday
#drugdiscovery#drugdevelopment#healthcarepic.twitter.com/bNYBj2ZVzi
-
Live on LinkedIn TOMORROW: Panelists Ralph Gareus (JAX) & Ana Zarubica (CIPHE, Marseille) talk about the many uses of humanized mice and how they are advancing
#immunooncology research in Europe. Follow us on LinkedIn to get a notification when it starts: https://www.linkedin.com/company/17529 pic.twitter.com/DLIvSIQvOa
-
Looking forward to Ana Anderson's talk today on the effect of steroid hormone signaling on CD8 T cells in the TME. Today in TAC auditorium at 4pm.
@YaleCancer@YaleIBIO#immunooncology -
#TOW2020 - Congratulations to Emma Reungoat for her excellent presentation on@genOway_SA's preclinical mouse models!!!

#genowayevents#immunooncology#immunotherapypic.twitter.com/ir85RkdxdD
-
Hey, Biotech/Pharma,
@ImaginAb BD team will be in the Cambridge/Boston area February 4-7, 2020. Contact busdev@imaginab.com to schedule a meeting and learn more about using CD8 ImmunoPET in your#immunooncology#clinicaltrial.#cancerimmunotherapy#immunotherapy -
20 years ago,
#WorldCancerDay
was established to acknowledge the impact of cancer on human life and society. Aiming to fight #Cancer, MorphoSys is developing#immunooncology therapies#IAmAndIWill
#antibody#CancerAwareness#DLBCL#leukemiapic.twitter.com/TiN1hvX5bE
-
Top
#ImmunoOncology Conferences for 2020. Click the link to download the spreadsheet. No signup necessary. http://ow.ly/kl2g50yaIoH pic.twitter.com/zXwv8YWYej
-
Deadlines are looming. Your Clinical Trial team needs reinforcements. Contact us today! info@milliconsults.com
#ClinicalDevelopment#ClinicalScientists#Pharmaceuticals#immunooncology#pharmacovigilance#drugsafety#clinicaltrials#clinicaldata#datareview#datacleaning#biotechpic.twitter.com/z02UPMQQwn -
IO-focused biotechs can still employ traditional
#oncology clinical trial parameters and processes, but considerations distinct to#immunooncology studies present unique scientific & operational challenges for even the most seasoned biotech executives. http://bit.ly/36OuNWW pic.twitter.com/GqNSHgPSxr
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.